Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | RBP4 | P02753 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9712354 | 0.88 | ALDH1A1 (0.42) | ALDH1A1ALOX15TDP1TSHRCA2 | |
| SCHEMBL9657789 | 0.87 | ALDH1A1 (0.48) | ALDH1A1ALOX15TDP1TSHRCA2 | |
| SCHEMBL4111692 | 0.83 | ALDH1A1 (0.50) | ALDH1A1ALOX15TDP1TSHRGAA | |
| SCHEMBL28009175 | 0.83 | ALDH1A1 (0.43) | ALDH1A1ALOX15TDP1TSHRCA2 | |
| SCHEMBL1148444 | 0.82 | ALDH1A1 (0.50) | ALDH1A1ALOX15TDP1TSHRCA2 | |
| SCHEMBL8055375 | 0.82 | CA2 (0.43) | ALDH1A1ALOX15TDP1TSHRCA2 | |
| SCHEMBL30706305 | 0.82 | CA2 (0.43) | ALDH1A1ALOX15TDP1TSHRCA2 | |
| SCHEMBL18131351 | 0.80 | ALDH1A1 (0.47) | ALDH1A1ALOX15TDP1TSHRCA2 | |
| SCHEMBL6949321 | 0.80 | ALDH1A1 (0.50) | ALDH1A1ALOX15TSHRCA2GAA | |
| SCHEMBL39249 | 0.80 | ALDH1A1 (0.56) | ALDH1A1ALOX15TDP1TSHRCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3162819-B1 | IMPROVED ZIEGLER-NATTA CATALYST SYNTHESIS AND PROCESS THEREOF | INDIAN OIL CORP LTD (IN) | 2018-09-05 | — | — | EP | claimed |
| US-9896523-B2 | Ziegler-Natta catalyst synthesis and process thereof | INDIAN OIL CORPORATION LIMITED (IN) | 2018-02-20 | — | — | US | claimed |
| EP-3206695-A1 | SCALABLE SYNTHESIS OF REDUCED TOXICITY DERIVATIVE OF AMPHOTERICIN B | The Board of Trustees of the University of Illionis (US) | 2017-08-23 | — | — | EP | claimed |
| EP-3162819-A1 | IMPROVED ZIEGLER-NATTA CATALYST SYNTHESIS AND PROCESS THEREOF | Indian Oil Corporation Limited (IN) | 2017-05-03 | — | — | EP | claimed |
| US-20160376384-A1 | ZIEGLER-NATTA CATALYST SYNTHESIS AND PROCESS THEREOF | INDIAN OIL CORPORATION LIMITED (IN) | 2016-12-29 | — | — | US | claimed |
| CN-104177388-B | A kind of bridging bisamide base ytterbium and its preparation method and application | 苏州大学 | 2016-08-17 | — | — | CN | claimed |
| WO-2016061437-A1 | SCALABLE SYNTHESIS OF REDUCED TOXICITY DERIVATIVE OF AMPHOTERICIN B | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2016-04-21 | — | — | WO | claimed |
| CN-104211927-A | Novel conductive photosensitive polymer | NANO & ADVANCED MATERIALS INST LTD | 2014-12-17 | — | — | CN | claimed |
| WO-2014059436-A1 | ELECTRONIC TUNING OF SITE SELECTIVITY | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2014-04-17 | — | — | WO | claimed |
| US-20100206760-A1 | ADHESIVE ARTICLE | BASF SE (DE) | 2010-08-19 | — | — | US | claimed |
| US-20090110856-A1 | ADHESIVE ARTICLE | BASF SE (DE) | 2009-04-30 | — | — | US | claimed |
| WO-2009043907-A1 | AN ADHESIVE ARTICLE | BASF SE (DE) | 2009-04-09 | — | — | WO | claimed |
| EP-4622465-A1 | HYGIENIC TREATMENT OF SURFACES WITH COMPOSITIONS COMPRISING HYDROPHOBICALLY MODIFIED ALPHA-GLUCAN DERIVATIVE | Nutrition & Biosciences USA 4, Inc. (US) | 2025-10-01 | — | — | EP | disclosed |
| US-12195432-B2 | 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-01-14 | — | — | US | disclosed |
| US-20240417379-A1 | P2X4 RECEPTOR ANTAGONIST | NIPPON CHEMIPHAR CO., LTD (JP) | 2024-12-19 | — | — | US | disclosed |
| US-12116351-B2 | P2X4 receptor antagonist | NIPPON CHEMIPHAR CO., LTD (JP) | 2024-10-15 | — | — | US | disclosed |
| US-4205016-A | Multifunctional lithium containing initiator | THE DOW CHEMICAL COMPANY (US) | 1980-05-27 | — | — | US | disclosed |
| US-4201729-A | CONTAINING BUTADIENE AND/OR ISOPRENE UNITS | THE DOW CHEMICAL COMPANY (US) | 1980-05-06 | — | — | US | disclosed |
| US-4200718-A | Multifunctional lithium containing initiator | THE DOW CHEMICAL COMPANY (US) | 1980-04-29 | — | — | US | disclosed |
| US-3954754-A | ANTIHYPERTENSIVES | SANDOZ LTD. (CH) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240417379-A1 | P2X4 RECEPTOR ANTAGONIST | P2RX7, P2RX1, P2RX2 | ALDH1A1 3045/4885ALOX15 2387/4885TDP1 3916/4885 |
| US-12116351-B2 | P2X4 receptor antagonist | P2RX7, P2RX1, P2RX2 | ALDH1A1 3019/4885ALOX15 1857/4885TDP1 4154/4885 |
| US-12195432-B2 | 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases | PPARG, PPARA, PPARD | ALDH1A1 1659/4885ALOX15 901/4885TDP1 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.